Kylix Bio, Inc. — Form D
Kylix Bio, Inc. of DOVER, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-01-26. The offering totals $12.0M, of which $850K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-01-26
- Form: D
- Accession: 0002106870-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $850K
- Remaining: $11.2M
- Minimum investment: $50K
- Investors: 5
- Date of first sale: 2026-01-15
- Revenue range: Decline to Disclose
- SEC file number: 021-571108
Issuer
- Name: Kylix Bio, Inc.
- CIK: 0002106870
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 8 THE GREEN, SUITE A, DOVER, DE, 19901
- Phone: 949-278-8398
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Madeleine F. Clarfield | Director | Dover, DE |
| Catherine P.W. Illingworth | Director | Dover, DE |
| Hunter P.W. Watts | Director | Dover, DE |
| Catherine P.W. Illingworth | Executive Officer | Dover, DE |
More